A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
about
A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the USSafety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
P2860
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A role for the intranasal form ...... reatment of allergic rhinitis.
@en
type
label
A role for the intranasal form ...... reatment of allergic rhinitis.
@en
prefLabel
A role for the intranasal form ...... reatment of allergic rhinitis.
@en
P2093
P2860
P50
P356
P1433
P1476
A role for the intranasal form ...... reatment of allergic rhinitis.
@en
P2093
Laura Bonzano
Marcello Montagni
Valerie Melli
P2860
P304
P356
10.4155/TDE.15.7
P577
2015-04-27T00:00:00Z